Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 188 of 623

Advanced search

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.

24/7 Wall St.Original source

🇪🇺Aug 25Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Identification and development of novel colorectal cancer biomarkers via state-of-the-art liquid biopsy approaches

CORDISOriginal source

🇪🇺Aug 25Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: A holistic approach to training a new generation of scientists in marine biodiscovery

CORDISOriginal source

🇪🇺Aug 25Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Next-generation AAV vectors for liver-directed gene therapy

CORDISOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences Announces AURORA Phase 3 Acne Trial on Track to Begin Enrollment in Q4 2026

Quiver QuantitativeOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

BRM424 Phase 2 Enrollment Complete with Safety Profile Superior to Existing Therapies; Q4 Data Readout Paves Way for Year-End Licensing Deal

finance.biggo.comOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026

The Manila TimesOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

The End of US Biotech Dominance?

PharmTech.comOriginal source

🇩🇪Aug 25Researchklinikum.uni-heidelberg.deTier 2 · Direct publisher

13,2 Millionen Euro für neue Immuntherapien gegen Ewing-Sarkome bei Kindern und Jugendlichen

Universitätsklinikum HeidelbergOriginal source

🇺🇸Aug 25Researchaacr.orgTier 2 · Direct publisher

Driving CAR T-cell Therapy in New Directions

AACROriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Sagimet's acne pill trial plans to enroll about 800 U.S. patients, including 450 teens

Stock TitanOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Celea Therapeutics Will Present Phase 3 Trial Design for Idiopathic Pulmonary Fibrosis and Key Insights from a Deupirfenidone Drug-Drug Interaction Study at the Upcoming European Respiratory Society (ERS) Congress

Business WireOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology

Business WireOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

ACT Brief: Payment Performance as Operational Brand, Speed and Discipline in Biotech Development Strategy, and Non-GLP-1 Obesity Candidate Licensing

Applied Clinical Trials OnlineOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week

AOL.comOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Shanghai Fosun Pharmaceutical: Revenue up 4.75% YoY, adjusted net profit up 19.09%, innovation and global expansion drive growth

TradingViewOriginal source

🌍Aug 25discoverynews.google.comTier 2 · Trade media

Young startups miss out on biotech venture funding rebound, MassBio says

BioPharma DiveOriginal source

🌍Aug 25Industryproqr.comTier 1 · Company source

Meet Carles - Researcher

ProQROriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

KSI-101 completes first pivotal cohort in phase 3 PEAK trial | Eye Care Network - Modern Retina

Ophthalmology Times EuropeOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

$3.3M project to study opioid treatment during breastfeeding

Binghamton UniversityOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Shanghai Fosun Pharmaceutical H1 Net Profit Up 1.15% Y/Y

TradingViewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Mumbai: Cafe Cadell FSSAI Licence Suspended Over Food Safety Violations

lokmattimes.comOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

MMRV programme: information for healthcare practitioners

This guidance is for health practitioners implementing the MMRV (measles, mumps, rubella and varicel...

UK Health Security AgencyOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Ieq Capital LLC Takes Position in Ultragenyx Pharmaceutical Inc. $RARE

MarketBeatOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

World Health Expo Broadens Focus on Pharma, Biotech and Longevity

The Indian PractitionerOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Rebuilding America's Pharmaceutical Backbone Through Small-Batch Manufacturing

Pharmaceutical OnlineOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

What "Made in Europe" will mean for critical medicines

The Pharma LetterOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Newly Approved Psoriasis Pill Expands Treatment Options

Technology NetworksOriginal source

🇩🇪Aug 25Mediacharite.deTier 2 · Direct publisher

Charité-Forschung auf der ISS: Hilft Muskelstimulation im All?

Charité - Universitätsmedizin Berlin (EN)Original source

🇩🇪Aug 25Researchcharite.deTier 2 · Direct publisher

Charité research on the ISS: Can muscle stimulation help astronauts stay strong in space?

Charité - Universitätsmedizin Berlin (EN)Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Newly Approved Psoriasis Pill Expands Treatment Options

Technology NetworksOriginal source

🌍Aug 25discoverynews.google.comTier 2 · Trade media

Vacant lab space, shrinking workforce put Mass. in ‘unique position’ for biotech bounceback

Fierce BiotechOriginal source

🇯🇵Aug 25Industrynippon-shinyaku.co.jpTier 1 · Company source

REGENXBIO社のムコ多糖症Ⅱ型治療薬「RGX-121」に関する規制当局対応の最新情報についてのお知らせ

Nippon Shinyaku NewsOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Bio-Works Technologies Secures Medicine Development Deal with US Biotech Company

marketscreener.comOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Closing the data integrity gap in pharmaceutical quality control

European Pharmaceutical ReviewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Daewoong Pharma prepares for Indonesia halal rules ahead of October rollout

Korea Biomedical ReviewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Rznomics to join Eli Lilly's San Diego biotech incubator

Korea Biomedical ReviewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Manufacturing Survival: Gianluca Costantini and Maziyar Ghiabi Draw Iran’s Pharmaceutical Sovereignty

ChannelDrawOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

Meningococcal disease: transmission parameters in outbreak contexts

Evidence of the infectious period, incubation period and transmission measures of meningococcal dise...

UK Health Security AgencyOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

Meningococcal disease: transmission and associated behaviours in outbreaks in closed social congregation settings

Evidence of the source or route of transmission and behaviours associated with transmission in menin...

UK Health Security AgencyOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

Meningococcal disease: routes of transmission

Evidence of the most common routes of transmission of meningococcal infection.

UK Health Security AgencyOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

Meningococcal disease: public health and social measures to reduce or prevent transmission

Evidence of the effectiveness of PHSM when implemented to reduce or prevent transmission of meningoc...

UK Health Security AgencyOriginal source

🇺🇰Aug 25Regulatorygov.ukTier 1 · Regulatory source

Meningococcal disease: impact of vaping on transmission

Evidence of the impact of the use of vapes or shisha pipes on transmission of meningococcal infectio...

UK Health Security AgencyOriginal source

🇫🇷Aug 25Regulatoryleem.orgTier 1 · Regulatory source

Michel Bellandi est élu au Conseil d’administration du Leem

LEEM FranceOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Moderna founder expects new paradigm in cancer treatment

medwatch.comOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

CHA Biotech wins $2.3 mil. grant for lung disease cell therapy

Korea Biomedical ReviewOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Merck and Moderna's individualised mRNA melanoma vaccine just won a Phase 3 trial outright — 1,137 patients, randomised two-to-one, both the primary and key secondary endpoint met — and the companies still won't say by how much until a medical conf

Space DailyOriginal source

🌍Aug 25Mediaskpharmteco.comTier 3 · Secondary coverage

GLP-1 Peptides Around the World Part III: EU Evolution – Expanded Expectations and Emerging Enforcement

SkpharmtecoOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Biotech Stocks At 52-Week Highs - VOGX, PHVS, SOLV, IKT, HTFL

RTTNewsOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

164,813 Shares in Ultragenyx Pharmaceutical Inc. $RARE Bought by Deutsche Bank AG

MarketBeatOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Karnataka FDA orders suspension of food licences over online sale of Datura seeds, fruits

DevdiscourseOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

The pharmaceutical bio business, which SK Group has been investing in for a long time, is making ful..

매일경제Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Generic lenacapavir for HIV prevention moves closer to India with CDSCO waiver of local Phase 3 trials

ThePrintOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

mRNA Cancer Vaccine Trial Succeeds, Biotech Sector Sees Catalyst

NAI500Original source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

ATG-201 Clears Australian Approval for Phase I Trial in B-Cell Autoimmune Diseases

The Clinical Trial VanguardOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Astellas Initiates Phase 3 Study of ASP2138 in CLDN18.2-Positive Gastric Cancer

The Clinical Trial VanguardOriginal source

🇫🇮Aug 25Devicesaiforia.comTier 1 · Company source

Aiforia and Stratipath partner to expand access to AI-driven precision diagnostics in oncology

AiforiaOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Funding Shift: Out-licensing Deals Surpass IPOs in H1 2026 - News and Statistics

IndexBoxOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Food Safety Crackdown: MCA Outlets, Midday Meal Center & School Eateries Under Lens – India Today - India Today

India TodayOriginal source

🌍Aug 25discoverynews.google.comTier 3 · Aggregated media

Can AI and Traditional Chinese Medicine Work Together to Develop New APIs?

FinancialContentOriginal source